Recombinant Human Tenascin XB2 Protein, CF


There are currently no images for Tenascin XB2 (6999-TN).

Every product we sell is backed by Novus' 100% Guarantee. If you have used this product, please submit your images and reviews to earn reward points.

Product Details

Reactivity HuSpecies Glossary
Applications Bioactivity

Order Details

Recombinant Human Tenascin XB2 Protein, CF Summary

Details of Functionality
Measured by the ability of the immobilized protein to support the adhesion of Saos‑2 human osteosarcoma cells.

The ED50 for this effect is 0.5-2.0 μg/mL.

Optimal dilutions should be determined by each laboratory for each application.

Chinese Hamster Ovary cell line, CHO-derived human Tenascin XB2 protein
Met1-Gly673, with a C-terminal 6-His tag
Accession #
N-terminal Sequence
Structure / Form
Protein/Peptide Type
Recombinant Proteins
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain
Endotoxin Note
<0.01 EU per 1 μg of the protein by the LAL method.


  • Bioactivity
Theoretical MW
74.8 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
80-95 kDa, reducing conditions

Packaging, Storage & Formulations

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.
Lyophilized from a 0.2 μm filtered solution in PBS.
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain
Reconstitution Instructions
Reconstitute at 400 μg/mL in PBS.


This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Recombinant Human Tenascin XB2 Protein, CF

  • Tenascin XB2
  • TNXB2


Tenascin X (TNX) is a 450 kDa, 4266 amino acid (aa) extracellular matrix glycoprotein belonging to the tenascin family of adhesion proteins (1, 2). Tenascins are modular proteins containing heptad, EGF‑like and fibronectin type III repeats and a C‑terminal fibrinogen‑like domain (1 ‑ 3). The Tenascin XB2 form, also called XB‑S or XB‑short, is transcribed from a separate promoter, producing a 74 kDa protein that consists of the C‑terminal 673 aa of the full‑length TNX (3 ‑ 5). Of the TNX domains, Tenascin XB2 contains only the last 4 of ~32 fibronectin type III (FnIII) repeats and the C‑terminal fibrinogen‑like globular domain, along with some of the N‑glycosylation and serine phosphorylation sites (3 ‑ 5). Human Tenascin XB2 shares 84% aa sequence identity with corresponding regions of mouse and rat TNX. Tenascin XB2 is expressed mainly in the adrenal gland, with minor amounts of mRNA detected in the small intestine, lung and spleen (3, 6). It is also found in some human cell lines, such as MCF7, H1299 and HeLa, and can be induced by hypoxia in MCF‑7 cells (6, 7). In contrast, full‑length TNX is prominent in muscle and connective tissue, and deletion or mutation of TNX is one cause of human joint hypermobility syndromes such as the Ehlers‑Danlos syndrome (1 ‑ 3, 6, 8, 9). Tenascin XB2 lacks an RGD integrin binding site between FnIII 10 and 11, and decorin/collagen‑binding sites that include the EGF‑like repeats, but retains the collagen‑binding fibrinogen‑like domain and could conceivably interfere with collagen crosslinking and fibril formation (4, 9). However, a 75 kDa plasma form that overlaps with the sequence of Tenascin XB2 binds tropoelastin but not collagens (10). At least a portion of Tenascin XB2 is expressed in the cytoplasm and is co‑localized with the mitotic motor kinesin, Eg5, during interphase and mitosis (6, 7).

  1. Hsia, H. and J.E. Schwarzbauer (2005) J. Biol. Chem. 280:26641.
  2. Bristow, J. et al. (1993) J. Cell Biol. 122:265.
  3. Speek, M. et al. (1996) Hum. Mol. Genet. 5:1749.
  4. Tee, M.K. et al. (1995) Genomics 28:171.
  5. Swiss-Prot accession P22105.
  6. Kato, A. et al. (2008) Exp. Cell Res. 314:2661.
  7. Endo, T. et al. (2009) Mol. Cell. Biochem. 320:53.
  8. Zweers, M. et al. (2004) Arthritis Rheum. 50:2742.
  9. Bristow, J. et al. (2005) Am. J. Med. Genet. C Semin. Med. Genet. 139C:24.
  10. Egging, D.F. et al. (2007) FEBS J. 274:1280.

Publications for Tenascin XB2 (6999-TN) (0)

There are no publications for Tenascin XB2 (6999-TN).
By submitting your publication information earn gift cards and discounts for future purchases.

Reviews for Tenascin XB2 (6999-TN) (0)

There are no reviews for Tenascin XB2 (6999-TN). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

FAQs for Tenascin XB2 (6999-TN) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Additional Tenascin XB2 Products

Blogs on Tenascin XB2

There are no specific blogs for Tenascin XB2, but you can read our latest blog posts.

Contact Information

Product PDFs


Concentration Calculator

The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.


Review this Product

Be the first to review our Recombinant Human Tenascin XB2 Protein, CF and receive a gift card or discount.


Gene Symbol TNXB